Liver tumors were more common in mice lacking a stress protein
Experiments in mice found poorer survival and early liver injury that progressed to chronic inflammation and scarring as the animals aged.
Our read
Mechanisms- Studied:
- Experiments in mice lacking OMA1
- What changed:
- Mice lacking OMA1 developed primary liver tumors more often
- The catch:
- Drug effects on liver tumors were not measured; experiments used genetic deletion
- In the record:
- One of 4 papers on OMA1 on record: none yet with results in people, 2 in animals.
Editor of record: Boris Djordjevic · AgingResearch.News
Mice lacking OMA1, a protein that coordinates stress responses in the cell’s energy-producing structures, developed primary liver tumors more often and had poorer survival in animal experiments. A stress-response pathway stayed persistently active without OMA1, promoting early liver injury. This progressed to chronic inflammation and fibrosis, or tissue scarring, as the mice aged.
Exhausted T cells—immune cells with reduced function—gradually accumulated in their livers, facilitating tumor progression. Deleting OMA1 specifically in hepatocytes, the liver’s main working cells, was sufficient to trigger stress signaling, liver-cell death and immune exhaustion. Other experiments indicated that losing OMA1 from the liver’s working cells increased the liver’s ability to provoke an immune response.
Why it matters
The authors suggest that immune surveillance—the ability to recognize threats—during liver aging relies on OMA1 in the liver. They say the findings should guide efforts to develop safe therapies targeting this protein.
Caveats
The experiments tested genetic deletion in mice, not drugs targeting OMA1 in people. The abstract does not give group sizes, limiting assessment of the tumor and survival results.
The paper
OMA1 protects from liver injury and tumorigenesis during aging by controlling hepatic immunogenicity
Spanish National Centre for Cardiovascular Research; Instituto de Salud Carlos III
The EMBO Journal, Jun 23, 2026, Open access
Comments
Be the first to comment.